Shukra Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 6.50 | 14.74 | 11.59 |
| Operating Expense | 4.07 | 5.95 | 6.65 |
| Net Profit | 1.03 | 5.39 | 3.16 |
| Net Profit Margin | 15.85 | 36.57 | 27.26 |
| Earning Per Share | 0.02 | 0.12 | 0.72 |
| EBIDTA | 2.50 | 8.78 | 4.90 |
| Effective Tax Rate | 16.87 | 24.83 | 18.02 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 6.50 |
| Operating Expense | 4.07 |
| Net Profit | 1.03 |
| Net Profit Margin | 15.85 |
| Earning Per Share | 0.02 |
| EBIDTA | 2.50 |
| Effective Tax Rate | 16.87 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 74.57 | 58.83 | 20.49 |
| Operating Expenses Annual | 55.17 | 53.47 | 17.60 |
| Operating Profit Annual | 22.22 | 6.56 | 2.97 |
| Interest Annual | 0.29 | 0.28 | 0.29 |
| Depreciation | 2.05 | 1.84 | 1.66 |
| Net Profit Annual | 18.54 | 4.41 | 0.75 |
| Tax Annual | 1.35 | 0.04 | 0.27 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 74.57 |
| Operating Expenses Annual | 55.17 |
| Operating Profit Annual | 22.22 |
| Interest Annual | 0.29 |
| Depreciation | 2.05 |
| Net Profit Annual | 18.54 |
| Tax Annual | 1.35 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 3.97 | 0.29 | 0.50 |
| Cash Flow from Operations | -5.20 | 3.17 | 7.99 |
| Cash Flow from Investing | -1.20 | -4.43 | -1.53 |
| Cash Flow from Financing | 12.41 | 4.94 | -6.68 |
| Cash Flow at the End | 9.98 | 3.97 | 0.29 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 3.97 |
| Cash Flow from Operations | -5.20 |
| Cash Flow from Investing | -1.20 |
| Cash Flow from Financing | 12.41 |
| Cash Flow at the End | 9.98 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 29.80 | 11.15 | 14.49 |
| PBIT Margin (%) | 27.05 | 8.02 | 6.39 |
| PBT Margin (%) | -66.27 | -20.69 | -15.67 |
| Net PROFIT Margin (%) | 24.86 | 7.50 | 3.66 |
| Return On Networth / Equity (%) | 44.71 | 21.18 | 4.69 |
| Return On Networth /Employed (%) | 44.16 | 18.84 | 5.81 |
| Return On Assets (%) | 40.53 | 17.54 | 3.33 |
| Total Debt / Equity (X) | 0.10 | 0.20 | 0.41 |
| Asset Turnover Ratio (%) | 1.63 | 2.34 | 0.91 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 29.80 |
| PBIT Margin (%) | 27.05 |
| PBT Margin (%) | -66.27 |
| Net PROFIT Margin (%) | 24.86 |
| Return On Networth / Equity (%) | 44.71 |
| Return On Networth /Employed (%) | 44.16 |
| Return On Assets (%) | 40.53 |
| Total Debt / Equity (X) | 0.10 |
| Asset Turnover Ratio (%) | 1.63 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 19.94 | 20.23 | 17.58 |
| Total Current Assets Annual | 56.23 | 53.07 | 15.87 |
| Non Current Assets Annual | 21.60 | 21.89 | 19.24 |
| Total Shareholders Funds Annual | 57.64 | 25.30 | 16.35 |
| Total Assets Annual | 77.84 | 74.97 | 35.11 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 19.94 |
| Total Current Assets Annual | 56.23 |
| Non Current Assets Annual | 21.60 |
| Total Shareholders Funds Annual | 57.64 |
| Total Assets Annual | 77.84 |
No Data Availabe
